HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway.

AbstractOBJECTIVE:
Non-alcoholic fatty liver disease (NAFLD) is an aberrant lipid metabolism disease. Hypoxia inducible factor-1 (HIF-1α) is a transcription factor which plays an important part in adapting lower oxygen condition. Here, we aimed to clarify the relationship between HIF-1α and NAFLD.
METHODS:
HepG2 cells was stimulated by oleic acid (OA) and palmitic acid (PA) to establish in vitro model of NAFLD. The expression of lipid metabolism-related genes, the binding of PPARα to HIF-1α promoter, the lipid deposition, and oxidative stress were detected by qRT-PCR, western blot, Chip assay, Oil Red O staining and ELISA assays, respectively.
RESULTS:
HIF-1α silence promoted lipid accumulation in NAFLD cells, accompanying by the significantly increased contents of TG (triglyceride) and ApoB (apolipoprotein B). In HepG2 cells treated with OA/PA, the expression of lipid metabolism-related genes and proteins, including APOE, A2m, TNFRSF11B, LDLr, and SREBP2, and the intracellular lipid deposition were up-regulated and further aggravated after silencing HIF-1α. In addition, the loss of HIF-1α could remarkably elevate MDA contents while inhibit the activities of beneficial antioxidant enzymes SOD and GSH-Px to activate oxidative stress, and promote the secretion of pro-inflammatory IL-6 and TNF-α to aggravate inflammation in NDFLD cells. PPARα positively bound to HIF-1α promoter. The silence of PPARα aggravated lipid deposition under normal or hypoxic environment in NAFLD cells. In addition, PPAR-α silence could decrease the expression of HIF-1α and ANGPTL4 in NAFLD cell model; moreover, the expression of APOE, A2m and TNFRSF11B and the production of TG and MDA were increased by PPAR-α suppression.
CONCLUSION:
HIF-1α plays a crucial role in the regulation of lipid metabolism through activating PPAR-α/ANGPTL4 signaling pathway in NAFLD.
AuthorsYan He, Wenhui Yang, Lulu Gan, Shijie Liu, Qing Ni, Yunxia Bi, Tun Han, Qian Liu, Hongyan Chen, Yang Hu, Yun Long, Li Yang
JournalGastroenterologia y hepatologia (Gastroenterol Hepatol) Vol. 44 Issue 5 Pg. 355-365 (May 2021) ISSN: 0210-5705 [Print] Spain
PMID33272734 (Publication Type: Journal Article)
CopyrightCopyright © 2020. Publicado por Elsevier España, S.L.U.
Chemical References
  • ANGPTL4 protein, human
  • Angiopoietin-Like Protein 4
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • PPAR alpha
  • PPARA protein, human
Topics
  • Angiopoietin-Like Protein 4 (antagonists & inhibitors)
  • Cells, Cultured
  • Gene Silencing
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, physiology)
  • Non-alcoholic Fatty Liver Disease (genetics)
  • PPAR alpha (antagonists & inhibitors)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: